ABSOLUTE: Randomized Comparison Between Sirolimus (Cypher)/Sirolimus - analogous (Xience; Promus) vs. Paclitaxel (Taxus vs. Costar) Eluting Stents in Coronary Lesions

      -A Single Center Experience by Dr. Alaide Chieffo (TCT 2007)

ENDEAVOR: Randomized Comparison Of Zotarolimus-Eluting And Paclitaxel-Eluting Stents In Patients With Coronary Artery Disease

      -Endeavor Safety: Pooled Analysis of Early and Late Safety of a Zotarolimus-Eluting Stent by Dr. Laura Mauri (TCT 2007)

ENDEAVOR 4: Randomized Comparison Of Zotarolimus-Eluting And Paclitaxel-Eluting Stents In Patients With Coronary Artery Disease-4

      -Trial Overview by Dr. Martin B. Leon (TCT 2007)

      -Three-year Follow-up by Dr. Martin B. Leon (TCT 2009)

ISAR-DESIRE 2: Drug-Eluting Stents For In-Stent Restenosis

      -Prospective, Randomized Trial of Paclitaxel- versus Sirolimus-Eluting Stents for Treatment of Coronary Restenosis in Sirolimus-Eluting Stents by Dr. Robert A. Byrne, et al. (TCT 2009)

ISAR-TEST 3: Intracoronary Stenting And Angiographic Restenosis Investigators – Test Efficacy Of Rapamycin-Eluting Stents With Different Polymer Coating Strategies

      -Rapamycin-Eluting Stents With Different Polymer Coating to Reduce Restenosis by Dr. J. Mehilli

ISAR-TEST 4: Intracoronary Stenting And Angiographic Restenosis Investigators – Test Efficacy Of Rapamycin-Eluting Stents With Different Polymer Coating Strategies

      -Randomized, Non-inferiority Trial of 3 Limus Agent-Eluting Stents With Different Polymer Coatings by Dr. J. Mehilli

LEADERS: Limus Eluted From A Durable Vs Erodable Stent Coating

      -2-Year Clinical Follow-Up by Dr. Volker Klauss (TCT 2009)

LONG DES II: Randomized Comparison of the Efficacy of Sirolimus-Eluting Stent Versus Paclitaxel-Eluting Stent in the Treatment of Long Native Coronary Lesions

      -Trial Overview by Dr. Seung-Jung Park (TCT 2006)

PACCOCATH ISR 1 and 2: Efficacy and Safety of Paclitaxel-Coated Balloons in Coronary In-Stent Restenosis

      -2-Year Results by Dr. Bruno Scheller (TCT 2007)

PACCOCATH ISR: Treatment of In-Stent Restenosis by Paclitaxel-Coated PTCA Balloons

      -Trial Overview by Dr. Bruno Scheller (AHA 2006)

Rapamycin- and Paclitaxel-Eluting Stents With Identical Biodegradable Polymeric Coating and Design Trial

      -Trial Overview by Dr. Rainer Wessley (ACC 2006)

REALITY: Prospective, Randomized, Multicenter Head-to-Head Comparison of Cypher and Taxus Stent Systems

      -8-Month Results by Dr. Marie-Claude Morice (ACC 2005)

SIRTAX: Sirolimus-Eluting Stent Compared With Paclitaxel-Eluting Stent For Coronary Revascularization

      -Trial Overview by Dr. Stephan Windecker (ACC 2005)

SIRTAX-LATE: Sirolimus-Eluting Stent Compared With Paclitaxel-Eluting Stent For Coronary Revascularization

      -5-Year Clinical and Angiographic Follow-up by Dr. Lorenz Räber, et al. (ACC 2009)

SPIRIT III: A Prospective, Randomized Trial Comparing an Everolimus-Eluting Stent and a Paclitaxel-Eluting Stent in Patients with Coronary Artery Disease

      -1-Year Follow-up and Subgroup Analysis by Dr. Gregg W. Stone (TCT 2007)

      -Clinical, Angiographic, and IVUS Results by Dr. Gregg W. Stone

SPIRIT IV: A Prospective, Randomized Trial Comparing an Everolimus-Eluting Stent and a Paclitaxel-Eluting Stent in Patients with Coronary Artery Disease

      -One Year Clinical Results by Dr. Gregg W. Stone (TCT 2009)

ZoMaxx-IVUS: Percutaneous Coronary revascularization Using a Trilayer Phosphorylcholine-Coated Zotarolimus-Eluting Stent

      -Trial Overview by Dr. A. Abazid (ACC 2006)

Who Are We?    Slide Downloading Policy   Financial Disclosure    We Do Not Promote Off Label Product Use    Copyright    Source of Slides    Editorial Policy    Links Policy    Privacy Policy   Access    CME Programs